Compare Citius Pharmaceuticals Inc (CTXR) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs ProShares Ultra Semiconductors — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.64M), while ProShares Ultra Semiconductors trades at $96.28. The key difference: ProShares Ultra Semiconductors is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | USD | |
|---|---|---|
Market Cap | $14.64M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.82 | $113.53 |
52-Week Low | $0.53 | $39.58 |
Enterprise Value | $10.86M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
